ouabain has been researched along with lissamine rhodamine b in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, DG; Ballard, HJ; Balnave, CD; Bourreau, JP; Yeung, EW | 1 |
| Chang, HS; Chang, WL; Chen, IS; Guh, JH; Hsu, JL; Hsu, LC; Kung, FL; Leu, WJ; Liu, FL; Yu, CC | 1 |
2 other study(ies) available for ouabain and lissamine rhodamine b
| Article | Year |
|---|---|
Development of T-tubular vacuoles in eccentrically damaged mouse muscle fibres.
Topics: Animals; Diffusion; Enzyme Inhibitors; Extracellular Space; Fluorescent Dyes; In Vitro Techniques; Isometric Contraction; Mice; Microscopy, Confocal; Muscle Contraction; Muscle Fibers, Skeletal; Muscle, Skeletal; Ouabain; Rhodamines; Sodium-Potassium-Exchanging ATPase; Vacuoles | 2002 |
Epi-reevesioside F inhibits Na+/K+-ATPase, causing cytosolic acidification, Bak activation and apoptosis in glioblastoma.
Topics: Antineoplastic Agents; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; Brain Neoplasms; Calcium; Cell Line, Tumor; Cell Proliferation; Cytosol; Flow Cytometry; Glioblastoma; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Membrane Potential, Mitochondrial; Ouabain; Potassium; Protein Structure, Tertiary; Rhodamines; Saponins; Sodium; Sodium-Potassium-Exchanging ATPase | 2015 |